Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS–QoL questionnaire

RJ Nijenhuis, AJ Smeets, M Morpurgo… - Cardiovascular and …, 2015 - Springer
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

WJ van Rooij, PNM Lohle - Cardiovascular and Interventional Radiology, 2015 - osti.gov
PurposeThis study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo… - Cardiovascular and …, 2015 - inis.iaea.org
Nijenhuis, RJ; Smeets, AJ; Morpurgo, M.; Boekkooi, PF; Reuwer, PJHM; Smink, M.; Rooij,
WJ van; Lohle, PNM, E-mail: nijenhuis@ maastrichtuniversity. nl, E-mail: a. smeets …

Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS-QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo… - Cardiovascular and …, 2015 - search.proquest.com
Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel
Microspheres: Three-Year Clinical Follow Page 1 CLINICAL INVESTIGATION ARTERIAL …

[PDF][PDF] Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo, PF Boekkooi… - researchgate.net
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

[PDF][PDF] Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo, PF Boekkooi… - Citeseer
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire

RJ Nijenhuis, AJ Smeets… - Cardiovascular …, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo… - CardioVascular and …, 2015 - infona.pl
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

[PDF][PDF] Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL …

RJ Nijenhuis, AJ Smeets, M Morpurgo, PF Boekkooi… - academia.edu
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …

Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire.

RJ Nijenhuis, AJ Smeets, M Morpurgo… - Cardiovascular and …, 2014 - europepmc.org
Purpose This study was designed to assess midterm outcome of uterine artery embolisation
(UAE) for women with therapy-resistant adenomyosis using polyzene F-coated hydrogel …